GlaxoSmithKline: all 4,196 studies
Page 32 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- Promacta Pregnancy RegistryCompletedNCT01064336
- Immunogenicity, Safety & Reactogenicity of GSK Vaccine Tritanrix™-HepB/Hib2.5 Compared to GSK Vaccine Tritanrix™-HepB/Hiberix™CompletedNCT01061541Phase 2
- Sumatriptan and Naratriptan Pregnancy RegistryCompletedNCT01059604
- First Study in Humans With GSK424887CompletedNCT01059591Phase 1
- First Study in Humans With GSK206136CompletedNCT01059578Phase 1
- Effect Of Maraviroc On The Pharmacokinetics Of DigoxinCompletedNCT01056874Phase 1
- Milk-only Lactation Study for Patients on EltrombopagWithdrawnNCT01055600Phase 4
- Birth Defects Associated With Exposure to Lamotrigine in Pregnancy (EUROCAT)CompletedNCT01055327
- HIV Treatment and CVD EventsCompletedNCT01054638
- A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in HumansCompletedNCT01051700Phase 1
- PBMC (Peripheral Blood Mononuclear Cells) /Lymphocyte SPECT (Single Photon Emission Computerized Tomography) Imaging in Crohn's DiseaseCompletedNCT01051622Phase 1
- Repeat Dose Safety and Efficacy Study for Compound to Treat AnemiaCompletedNCT01047397Phase 2
- Post-marketing Surveillance Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in PhilippinesTerminatedNCT01046097
- Glibenclamide (Dose to be Titrated From Starting Dose of 5mg om) Plus Rosiglitazone 4mg om (Increased to 8mg om After 6 Months) and vs Glibenclamide (Dose to be Titrated With Starting Dose of 5mg om) Plus Placebo, Administered to Patients With Type 2 Diabetes MellitusCompletedNCT01045590Phase 4
- Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) ExposureWithdrawnNCT01045564Phase 2
- GSK962040 Drug-drug Interaction Study With KetoconazoleCompletedNCT01039974Phase 1
- PK Study of IV Formulation of GW856553CompletedNCT01039961Phase 1
- A Clinical Study to Assess the Effects of SRT2104 Upon Immobilization-Induced Skeletal Muscle Atrophy in Healthy Human VolunteersWithdrawnNCT01039909Phase 1
- A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a CapsuleCompletedNCT01039883Phase 1
- Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed IntoleranceCompletedNCT01039805Phase 2
- A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc.WithdrawnNCT01039610Phase 1
- Effects of the D3 Antagonist GSK598809 on Food Reward and ReinforcementCompletedNCT01039454Phase 1
- Regulatory Hycamtin(Oral) PMSCompletedNCT01037023
- GSK618334 Repeat Dose StudyCompletedNCT01036061Phase 1
- First Time in Human Study of Intravenous Interleukin-18 AntibodyCompletedNCT01035645Phase 1
- A Study to Assess Relative Bioavailability and Food Effect of New Formulations of GSK2248761CompletedNCT01031472Phase 1
- Study to Identify and Characterize Bacteria Causing Acute Otitis Media in Young Children in TurkeyWithdrawnNCT01031329
- First Time in Human StudyCompletedNCT01031186Phase 1
- A Clinical Trial to Assess the Safety of Oral SRT2104 and Its Effects on Vascular Dysfunction in Otherwise Healthy Cigarette Smokers and Subjects With Type 2 Diabetes MellitusCompletedNCT01031108Phase 1
- Study to Identify and Characterize Bacteria Causing Acute Otitis Media in South African ChildrenCompletedNCT01031082
- Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteersCompletedNCT01030939Phase 1
- Cantharidin-induced Skin Blister for Testing Anti-inflammatory Effects of MacrolidesCompletedNCT01026064Phase 1
- A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne VulgarisCompletedNCT01019603Phase 1
- A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2379 in Normal Healthy Male VolunteersCompletedNCT01018628Phase 1
- A Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects With Type 2 Diabetes MellitusCompletedNCT01018017Phase 2
- A Study of the Effects of Increasing Doses of a Drug for the Treatment of Nail FungusCompletedNCT01014962Phase 1
- Effect of SRT2104 on Endotoxin-induced InflammationCompletedNCT01014117Phase 1
- A Study of GSK573719 in Healthy Japanese Male SubjectsCompletedNCT01013974Phase 1
- Prevalence of Chronic Airway Obstruction in Subjects With a History of Cigarette Smoking in a Primary Care SettingCompletedNCT01013948
- A Study of HGS1029 in Subjects With Relapsed or Refractory Lymphoid MalignanciesTerminatedNCT01013818Phase 1
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Type 2 DiabeticsCompletedNCT01013766Phase 1
- Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's DiseaseCompletedNCT01009255Phase 2
- Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in AdultsWithdrawnNCT01008956Phase 2
- AVODART® Alopecia Post-marketing Surveillance (PMS)CompletedNCT01004809
- Regulatory AVAMYS Nasal Spray PMSCompletedNCT01001130
- Repeat Dose Study of Controlled-Release Paroxetine Tablets and Immediate-Release Paroxetine Tablets in Healthy Japanese Male SubjectsCompletedNCT01000857Phase 1
- Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate is Processed by the Body in Healthy Caucasian, Japanese, Korean and Chinese SubjectsCompletedNCT01000597Phase 1
- SCOT Registry: Small Cell Lung Cancer Treatment and OutcomeCompletedNCT00997061
- Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United KingdomCompletedNCT00996853
- A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of LapatinibCompletedNCT00996762Phase 1
- Phase I Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of GSK2256098 in Healthy VolunteersCompletedNCT00996671Phase 1
- An Open-label Single Dose Randomized, Parallel Group Study Followed by Single-blind Repeat Dosing, to Compare the Relative Bioavailability of GSK2212836.CompletedNCT00996268Phase 1
- Study to Assess Cardiac Conduction of GSK1349572CompletedNCT00996021Phase 1
- Evaluation of the Duration of Oral Combination Therapy in Type 2 Diabetes, Prior to the Initiation of Insulin in the UKCompletedNCT00995995
- Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Non Hodgkin's Lymphoma (NHL) Patients With Greater Than 25% Bone Marrow InvolvementCompletedNCT00992758Phase 1
- A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In IndiaNo longer availableNCT00992654
- Vestipitant 28-day Tolerance StudyCompletedNCT00992160Phase 2
- An Open-Label Pharmacodynamic Study of Bevacivumab and Pazopanib in Renal Cell CarcinomaCompletedNCT00992121Phase 1
- A Pharmacokinetic Study to Evaluate TREXIMET in Adolescents With Migraine and Healthy Subjects Administered at Three Doses.CompletedNCT00989625Phase 1
- Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 DaysCompletedNCT00989404Phase 1
- A Study to Investigate the Ability of GSK706769 to Maintain Clinical Remission After Withdrawal of Enbrel in Rheumatoid Arthritis PatientsWithdrawnNCT00979771Phase 2
- A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 DiabetesCompletedNCT00976261Phase 1
- Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of GSK573719 (LAMA) and GW642444 (LABA)Administered Individually and Concurrently in Healthy Japanese SubjectsCompletedNCT00976144Phase 1
- Effects of Repeat Dosing of GSK1521498CompletedNCT00976105Phase 1
- [11C]Carfentanil PET Study of GSK1521498CompletedNCT00976066Phase 1
- Regulatory TYKERB® Tablets PMSCompletedNCT00975988
- Phase 0 Microdose StudyCompletedNCT00975936Phase 1
- Dose-Escalation Study of GSK2126458CompletedNCT00972686Phase 1
- A Study of GW685698X in Healthy Japanese Male SubjectsCompletedNCT00972673Phase 1
- Extension Study of GI198745 to Treat Benign Prostatic HyperplasiaCompletedNCT00969072Phase 2
- Study in Neuropathic Pain Patients With Peripheral Nerve InjuryCompletedNCT00969059Phase 2
- Phase I Study of GSK233705 in Healthy Japanese Male SubjectsCompletedNCT00964405Phase 1
- A Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral SRT2104 Capsules Administered to Healthy Elderly Subjects for 28 DaysCompletedNCT00964340Phase 1
- Phase I Study of GW642444M in Healthy Japanese Male SubjectsCompletedNCT00964249Phase 1
- Validation Study of Multiple Probe Compounds for Drug Interaction EvaluationCompletedNCT00964106Phase 1
- A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer SubjectsCompletedNCT00955773Phase 1
- GSK2190915 Safety and Pharmacokinetic Study in Healthy Japanese SubjectsCompletedNCT00955383Phase 1
- Study of Salmeterol (SN408D) for Adult AsthmaCompletedNCT00950794Phase 4
- Safety, Blood Levels, Drug Interaction and Effects of Repeated Doses of GSK1034702CompletedNCT00950586Phase 1
- Subcutaneous Administration of Otelixizumab to T1DM PatientsCompletedNCT00946257Phase 1
- A Study to Evaluate the Effect of Repeat Doses of GW870086X in Mild to Moderate AsthmaticsCompletedNCT00945932Phase 2
- Positron Emission Tomography (PET) Study to Describe the Relationship Between Plasma Concentrations and Brain Gly-T1 Occupancy of GSK1018921 Over Time.CompletedNCT00945503Phase 1
- GSK1349572 Proton Pump Inhibitor Drug Interaction and Supratherapeutic Dose StudyCompletedNCT00942136Phase 1
- A Clinical Study to Assess the Effect of Food and Gender on the Pharmacokinetics of SRT2104 Administered as an Oral Suspension or Capsule Formulation to Normal Healthy VolunteersCompletedNCT00938275Phase 1
- Single Dose Study of Controlled-Release Paroxetine Tablets in Healthy Japanese Male SubjectsCompletedNCT00938184Phase 1
- A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.CompletedNCT00938158Phase 1
- A Clinical Study to Evaluate the Pharmacokinetics and the Absolute Bioavailability of SRT2104 Given as a 250mg Oral Suspension and Intravenous Microdose of 100 µg Carbon-14 Radio-labeled SRT2104 in Healthy Male SubjectsCompletedNCT00937872Phase 1
- Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan StudyCompletedNCT00937846Phase 1
- Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)CompletedNCT00935987Phase 1/2
- Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal ImpairmentCompletedNCT00935831Phase 1
- A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Normal Healthy Male VolunteersCompletedNCT00933530Phase 1
- Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of SRT2104 Administered to Normal Healthy Male VolunteersCompletedNCT00933062Phase 1
- Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol LBRA99No longer availableNCT00931086
- A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam.TerminatedNCT00929370Phase 1
- Relative Bioavailability Study in Healthy SubjectsCompletedNCT00924911Phase 1
- Study of Natural History of Human Papillomavirus (HPV) Infections in Adult Women With Recurrent Conizations in NorwayTerminatedNCT00924794
- Advair Pediatric Once-DailyCompletedNCT00920959Phase 3
- A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic MetastasesCompletedNCT00920803Phase 1
- Clinical Study to Assess the Effects of SRT2104 and Prednisolone on Biomarkers in Blood in Healthy VolunteersCompletedNCT00920660Phase 1
- GSK BHR Study (Sont)CompletedNCT00920543Phase 4